Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-18 | Dec-31-17 |
| Revenues | 60.5 | 48.1 | 29.8 | 0.0 |
| Revenue growth | 25.6% | | | |
| Cost of goods sold | 22.4 | 18.5 | 10.4 | 0.0 |
| Gross profit | 38.1 | 29.7 | 19.4 | 0.0 |
| Gross margin | 63.0% | 61.6% | 65.1% | |
| Sales and marketing | 16.3 | 16.2 | 8.4 | |
| Research and development | 13.1 | 12.2 | 10.0 | |
| General and administrative | 23.2 | 21.7 | 14.3 | 0.7 |
| EBITA | -14.5 | -20.4 | -13.3 | -0.7 |
| EBITA margin | -24.0% | -42.4% | -44.5% | |
| Amortization of intangibles | 14.6 | 14.7 | 0.4 | |
| EBIT | -29.1 | -35.1 | -13.7 | -0.7 |
| EBIT margin | -48.1% | -72.9% | -45.8% | |
| Pre-tax income | -53.0 | -44.3 | -15.7 | 3.9 |
| Income taxes | -0.8 | 2.4 | 0.8 | 0.0 |
| Tax rate | 1.6% | | | 0.0% |
| Net income | -53.8 | -41.9 | -18.0 | 3.9 |
| Net margin | -89.0% | -87.1% | -60.3% | |
| |
| Diluted EPS | ($0.94) | ($0.78) | | $0.06 |
| Shares outstanding (diluted) | 57.1 | 53.5 | | 69.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|